277 related articles for article (PubMed ID: 31493266)
1. Benefits of Fractal Approaches in Solid Dosage Form Development.
Abreu-Villela R; Kuentz M; Caraballo I
Pharm Res; 2019 Sep; 36(11):156. PubMed ID: 31493266
[TBL] [Abstract][Full Text] [Related]
2. Excipient Stability in Oral Solid Dosage Forms: A Review.
Darji MA; Lalge RM; Marathe SP; Mulay TD; Fatima T; Alshammari A; Lee HK; Repka MA; Narasimha Murthy S
AAPS PharmSciTech; 2018 Jan; 19(1):12-26. PubMed ID: 28895106
[TBL] [Abstract][Full Text] [Related]
3. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
Kołodziejczyk MK; Kołodziejska J; Zgoda MM
Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical aspects and implications of excipient variability in drug product performance.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Eur J Pharm Biopharm; 2017 Feb; 111():1-15. PubMed ID: 27845182
[TBL] [Abstract][Full Text] [Related]
5. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
Wenzel T; Stillhart C; Kleinebudde P; Szepes A
Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
[TBL] [Abstract][Full Text] [Related]
6. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
7. Impact Of Excipient Variability On Drug Product Processing And Performance.
Peng Soh JL; Liew CV; Sia Heng PW
Curr Pharm Des; 2015; 21(40):5890-9. PubMed ID: 26446469
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tablet formation of different lactoses by 3D modeling and fractal analysis.
Jelcic Z; Hauschild K; Ogiermann M; Picker-Freyer KM
Drug Dev Ind Pharm; 2007 Apr; 33(4):353-72. PubMed ID: 17523001
[TBL] [Abstract][Full Text] [Related]
9. Geometry of modified release formulations during dissolution--influence on performance of dosage forms with diclofenac sodium.
Dorożyński P; Kulinowski P; Jamróz W; Juszczyk E
Int J Pharm; 2014 Dec; 477(1-2):57-63. PubMed ID: 25311175
[TBL] [Abstract][Full Text] [Related]
10. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
[TBL] [Abstract][Full Text] [Related]
11. A Review of Disintegration Mechanisms and Measurement Techniques.
Markl D; Zeitler JA
Pharm Res; 2017 May; 34(5):890-917. PubMed ID: 28251425
[TBL] [Abstract][Full Text] [Related]
12. Review of Disintegrants and the Disintegration Phenomena.
Desai PM; Liew CV; Heng PWS
J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
14. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K
J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069
[TBL] [Abstract][Full Text] [Related]
15. Sodium alginate and alginic acid as pharmaceutical excipients for tablet formulation: Structure-function relationship.
Sanchez-Ballester NM; Bataille B; Soulairol I
Carbohydr Polym; 2021 Oct; 270():118399. PubMed ID: 34364633
[TBL] [Abstract][Full Text] [Related]
16. Miniaturized approach for excipient selection during the development of oral solid dosage form.
Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
[TBL] [Abstract][Full Text] [Related]
17. Assessment of disintegrant efficacy with fractal dimensions from real-time MRI.
Quodbach J; Moussavi A; Tammer R; Frahm J; Kleinebudde P
Int J Pharm; 2014 Nov; 475(1-2):605-12. PubMed ID: 25234864
[TBL] [Abstract][Full Text] [Related]
18. A new way of solid dosage form samples preparation for SEM and FTIR using microtome.
Šimek M; Grünwaldová V; Kratochvíl B
Pharm Dev Technol; 2014 Jun; 19(4):411-6. PubMed ID: 23611186
[TBL] [Abstract][Full Text] [Related]
19. FIP Guidelines for Dissolution Testing of Solid Oral Products.
Friedel HD; Brown CK; Barker AR; Buhse LF; Keitel S; Kraemer J; Morris JM; Reppas C; Sperry DC; Sakai-Kato K; Stickelmeyer MP; Shah VP
J Pharm Sci; 2018 Dec; 107(12):2995-3002. PubMed ID: 30148985
[TBL] [Abstract][Full Text] [Related]
20. Particle Engineering Via Mechanical Dry Coating in the Design of Pharmaceutical Solid Dosage Forms.
Qu L; Morton DA; Zhou QT
Curr Pharm Des; 2015; 21(40):5802-14. PubMed ID: 26446461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
